<DOC>
	<DOCNO>NCT01048502</DOCNO>
	<brief_summary>The purpose study well understand anti-inflammatory benefit two prescription medicine currently use help people cholesterol problem . Fish oil , eat certain kind fish supplement pill , use help control cholesterol reduce inflammation ( body 's response injury sickness ) . Lovaza® brand name prescription strength fish oil pill . In study , look Lovaza® work help reduce inflammation healthy volunteer . Tricor® brand name prescription fenofibrate pill . Fenofibrate prescription medicine many doctor give people high triglyceride ( fat blood ) level . In study , look Tricor® work help reduce inflammation healthy volunteer . Endotoxin lipopolysaccharide ( LPS ) small part bacteria ( longer live ) cause many effect similar bacterial infection human . However , administer small amount produce mild immune response much 'flu ' like illness . Within 1 ½ -3 hour give LPS vein , response consist fever , chill , headache , nausea vomit generalized ache pain occur last 6-8 hour . In addition flu like symptom , response cause temporary change cholesterol , triglyceride blood sugar . Different people respond differently LPS . We use LPS study bring temporary inflammatory response body compare responses people receive Lovaza® Tricor® responses people receive placebo ( pill contain medicine ) .</brief_summary>
	<brief_title>Fenofibrate Omega-3 Fatty Acid Modulation Endotoxemia</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Endotoxemia</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Men nonpregnant/lactating woman age 18 45 . Body Mass Index ( BMI ) ≥18 ≤30 Participants able give write informed consent willing comply studyrelated procedure . Known clinically manifest atherosclerotic cardiovascular disease , include coronary disease , cerebrovascular disease , peripheral vascular disease History diabetes mellitus Fasting glucose &gt; 126mg/dL screen History nonskin malignancy within previous 5 year Renal insufficiency define creatinine outside lab define normal range eGFR &lt; 60 ml/Kg/min Screening Visit History liver disease abnormal Liver Function Tests ( LFTs ) ( aspartate aminotransferase ( AST ) , alanine transaminase ( ALT ) , alkaline phosphatase , gammaglutamyl transpeptidase ( GGT ) &gt; 1.5x upper limit normal ( ULN ) ; bilirubin &gt; 2x ULN ) Screening Visit Men unwilling limit alcohol consumption &lt; 14 alcoholic drink per week &lt; 4 alcoholic drink per occasion ( American Medical Association/National Institute Alcohol Abuse Alcoholism ( AMA / NIAAA ) criteria `` risk '' usage level ) participate study Women unwilling limit alcohol consumption &lt; 7 alcoholic drink per week &lt; 3 alcoholic drink per occasion ( AMA / NIAAA criterion `` risk '' usage level ) participate study Total white blood cell count less equal 3.0 THO/uL Hemoglobin le 11.0 g/dL Any major active rheumatologic , pulmonary , dermatologic disease inflammatory condition minor active infection Selfreported history HIV positive First degree family history premature cardiovascular disease event ( father brother diagnose 55 year age ; mother sister diagnose 65 year age ) Patients undergone organ transplant Individuals currently use tobacco product do previous 30 day Treatment aspirin , Nonsteroidal Antiinflammatory Drugs ( NSAIDs ) , cyclooxygenase2 ( COX2 ) inhibitor , steroid immunomodulatory therapy 2 week prior Screening Visit Treatment statins , fibrates niacin 4 week prior Screening Visit . Current daily use Vitamin C &gt; 1000 mg , Beta carotene &gt; 1000 IU , vitamin A &gt; 5000 IU , vitamin E &gt; 400 IU , selenium &gt; 200 mcg Participants unwilling eliminate omega3 fatty acid ( eicosapentaenoic acid ( EPA ) + docosahexaenoic acid ( DHA ) ) supplement and/or fortify food , usual intake high omega3 fish ( tuna nonfried fish ) &gt; 3 4 serving per month assess simple screening questionnaire Positive urine pregnancy test result . Participation another clinical trial within previous 6 week prior Screening Visit . Poorly control blood pressure ( BP &gt; 160/110 ) antihypertensive medication . A diagnosis metabolic syndrome use updated 2004 National Cholesterol Education Program Adult Treatment Panel III ( NCEP ATPIII ) criterion . Any medical condition abnormal laboratory value judge clinically significant investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>healthy volunteer</keyword>
</DOC>